Serum γ-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population

Journal of Internal Medicine

Volumn 258, Issue 6, 2005, Pages 527-535

  Meisinger, C ^a,b   Lowel H ^b   Heier, M ^a,b   Schneider, A ^b   Thorand, B ^b  

^a KLINIKUM AUGSBURG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Diabetes; Epidemiology; Obesity; Risk factors

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; GERMANY; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL ANALYSIS; VALIDATION PROCESS;

ADULT; AGE DISTRIBUTION; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OBESITY; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 28244500484     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2005.01572.x     Document Type: Article

References (22)

1. Skinner HA, Holt S, Schuller R, Roy J, Israel Y. Identification of alcohol abuse using laboratory tests and a history of trauma. Ann Intern Med 1984; 101: 847-51.
2. Nilssen O, Forde OH, Brenn T. The Tromso study distribution and population determinants of gamma-glutamyltransferase. Am J Epidemiol 1990; 132: 318-26.
3. Nakanishi N, Suzuki K, Tatara K. Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 2004; 27: 1427-32.
4. Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesäniemi YA. Gammaglutamyl transpeptidase and the metabolic syndrome. J Intern Med 2000; 248: 230-8.
5. Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease. A feature of the metabolic syndrome. Diabetes 2001; 50: 1844-50.
6. Karp DR, Shimooku K, Lipsky PE. Expression of γ-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death. J Biol Chem 2001; 276: 3798-804.
7. Lee DH, Ha MH, Kim JH et al. Gamma-glutamyltransferase and diabetes - a 4 year follow-up study. Diabetologia 2003; 46: 359-64.
8. Whitfield JB. Gamma-glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263-355.
9. Lee DH, Jacobs DR, Gross M et al. γ-glutamyltransferase is a predictor of incident diabetes and hypertension: the CARDIA Study. Clin Chem 2003; 49: 1358-66.
10. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995; 142: 699-708.
11. Jousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyltransferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000; 31: 1851-5.
12. Nakanishi N, Nishina K, Li W, Sato M, Suzuki K, Tatara K. Serum γ-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med 2003; 254: 287-95.
13. Lee DH, Silventoinen K, Jacobs DR Jr, Jousilahti P, Tuomilehto J. Gamma-glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab 2004; 89: 5410-4.
14. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum γ-glutamyltransferase and risk of NIDDM. Diabetes Care 1998; 21: 732-7.
15. Keil U, Liese AD, Hense HW et al. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Eur Heart J 1998; 19: 1197-207.
16. Meisinger C, Thorand B, Schneider A, Stieber J, Doering A, Loewel H. Sex differences in risk factors for incident type 2 diabetes mellitus. The MONICA Augsburg Cohort Study. Arch Intern Med 2002; 162: 82-9.
17. Chitturi S, Abeygunasekera S, Farrell GC et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-9.
18. Yin M, Wheeler MD, Kono H et al. Essential role of tumor necrosis factor in alcohol-induced liver injury in mice. Gastroenterology 1999; 117: 942-52.
19. Targher G, Seidell JC, Tonoli M, Muggeo M, De Sandre G, Cigolini M. The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J Intern Med 1996; 239: 435-41.
20. Thorand B, Loewel H, Schneider A et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men. Results from the MONICA Augsburg Cohort Study, 1984-1998. Arch Intern Med 2003; 163: 93-9.
21. Hu FB, Stampfer MJ, Solomon CG et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 2001; 161: 1717-23.
22. Stevens J, Couper D, Pankow J et al. Sensitivity and specificity of anthropometries for the prediction of diabetes in a biracial cohort. Obes Res 2001; 9: 696-705.